ContractCougar Biotechnology, Inc. • May 3rd, 2006 • Blank checks • Delaware
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAW. THIS WARRANT AND SUCH SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE PLEDGED, TRANSFERRED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR DELIVERY OF AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE WITH THE ACT OR UNLESS SOLD IN FULL COMPLIANCE WITH RULE 144 UNDER THE ACT.
EMPLOYMENT AGREEMENTEmployment Agreement • May 3rd, 2006 • Cougar Biotechnology, Inc. • Blank checks • New York
This AGREEMENT (the “Agreement”) is made this 16th day of May 2003, by and between COUGAR BIOTECHNOLOGY, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and ALAN AUERBACH, residing at 447 Herondo Street, #208, Hermosa Beach, California 90254 (the “Executive”).
WARRANT To Purchase ______ Shares of Common Stock of COUGAR BIOTECHNOLOGY, INC.Cougar Biotechnology, Inc. • May 3rd, 2006 • Blank checks
This Warrant and the Securities issuable upon exercise of this Warrant have not been registered under the Securities Act of 1933 (the “1933 Act”) or under any state securities or “Blue Sky” laws (“Blue Sky Laws”). No transfer, sale, assignment, pledge, hypothecation or other disposition of this Warrant or the Securities issuable upon exercise of this Warrant or any interest therein may be made except (a) pursuant to an effective registration statement under the 1933 Act and any applicable Blue Sky Laws or (b) if the Corporation has been furnished with an opinion of counsel for the holder, which opinion and counsel shall be reasonably satisfactory to the Corporation, to the effect that no registration is required because of the availability of an exemption from registration under the 1933 Act and applicable Blue Sky laws.
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • May 3rd, 2006 • Cougar Biotechnology, Inc. • Blank checks
THIS FIRST AMENDMENT TO LICENSE AGREEMENT (hereinafter referred to as "FIRST Amendment") is made and entered into this 2nd day of June, 2004 (hereinafter the "Effective Date") by and between:
Portions herein identified by [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. LICENSE AGREEMENT between Cougar...License Agreement • May 3rd, 2006 • Cougar Biotechnology, Inc. • Blank checks
This Agreement (hereinafter referred to as this "Agreement"), effective as of this _________, 2005 (the ”Effective Date”), is entered into by and between LEO Pharma A/S, a corporation having its principal office at Industriparken 55, 2750 Ballerup, Denmark (hereinafter referred to as “LEO”), and Cougar Biotechnology Inc., a corporation duly organized and existing under the laws of the State of California with head quarters at 10940 Wilshire Blvd., Suite 600, Los Angeles, CA 90024, USA (”Cougar”).
SCIENTIFIC ADVISORY AGREEMENTScientific Advisory Agreement • May 3rd, 2006 • Cougar Biotechnology, Inc. • Blank checks • California
THIS SCIENTIFIC ADVISORY AGREEMENT (this "Agreement"), effective as of the ____ of December, 2003, is by and between ARIE BELLDEGRUN, M.D., having an address at _______________________________ (hereinafter referred to as "ADVISOR") and Cougar Biotechnology, Inc., a Delaware limited liability corporation having offices at 10940 Wilshire Blvd. Suite 600, Los Angeles, CA 90024 ("COUGAR").
SCIENTIFIC ADVISORY AGREEMENT AMENDMENT NO. 1Scientific Advisory Agreement • May 3rd, 2006 • Cougar Biotechnology, Inc. • Blank checks
This Amendment No. 1 (this “Amendment”) effective this 24th day of August, 2004 hereby amends that certain Scientific Advisory Agreement (the “Agreement”) between ARIE BELLDEGRUN, M.D., having an address at 10833 Le Conte Avenue, Los Angeles, CA 90095 (hereinafter referred to as "ADVISOR") and Cougar Biotechnology, Inc., a Delaware limited liability corporation having offices at 10940 Wilshire Blvd. Suite 600, Los Angeles, CA 90024 ("COUGAR"). Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to such term in the Agreement.
Portions herein identified by [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. EXCLUSIVE LICENSE AGREEMENT...Exclusive License Agreement • May 3rd, 2006 • Cougar Biotechnology, Inc. • Blank checks • Georgia
THIS LICENSE AGREEMENT is made and entered into as of this 23rd day of February, 2004 (hereinafter referred to as “Effective Date”), by and between EMORY UNIVERSITY, a non-profit Georgia corporation with offices located at Office of Technology Transfer, North Decatur Bldg., Suite 130, 1784 N. Decatur Road, Atlanta, Georgia 30322 USA (hereinafter referred to as “EMORY”), and COUGAR BIOTECHNOLOGY, INC. a for-profit California corporation with offices at 10940 Wilshire Blvd., Suite 600, Los Angeles, California 90024 USA (hereinafter referred to as “CBT”).
Portions herein identified by [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. LICENSE AGREEMENTLicense Agreement • May 3rd, 2006 • Cougar Biotechnology, Inc. • Blank checks • Delaware
This AGREEMENT is made by and between BTG INTERNATIONAL LTD., a British corporation with its principal place of business at 10 Fleet Place, Limeburner Lane, London, EC4M 7SB, England (“BTG”); and COUGAR BIOTECHNOLOGY INC., a Delaware Corporation with its principal place of business in Los Angeles, California, USA (“Licensee”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 3rd, 2006 • Cougar Biotechnology, Inc. • Blank checks • New York
THIS STOCK PURCHASE AGREEMENT ("Agreement") is entered into as of May 16, 2003, by and between HORIZON BIOMEDICAL INVESTMENTS, LLC (the "Purchaser") and COUGAR BIOTECHNOLOGY, INC., a Delaware Corporation having a business address at 787 Seventh Avenue, New York, NY 10019 (the "Corporation").
